| Antiobesity pharmacotherapy: new drugs and emerging targets GW Kim, JE Lin, ES Blomain, SA Waldman Clinical Pharmacology & Therapeutics 95 (1), 53-66, 2014 | 227 | 2014 |
| Thyroid carcinoma, version 2.2022, NCCN clinical practice guidelines in oncology RI Haddad, L Bischoff, D Ball, V Bernet, E Blomain, NL Busaidy, ... Journal of the National Comprehensive Cancer Network 20 (8), 925-951, 2022 | 219 | 2022 |
| Mechanisms of weight regain following weight loss ES Blomain, DA Dirhan, MA Valentino, GW Kim, SA Waldman International Scholarly Research Notices 2013 (1), 210524, 2013 | 167 | 2013 |
| Selective RAF inhibitor impairs ERK 1/2 phosphorylation and growth in mutant NRAS, vemurafenib‐resistant melanoma cells K Le, ES Blomain, U Rodeck, AE Aplin Pigment cell & melanoma research 26 (4), 509-517, 2013 | 91 | 2013 |
| Obesity-induced colorectal cancer is driven by caloric silencing of the guanylin–GUCY2C paracrine signaling axis JE Lin, F Colon-Gonzalez, E Blomain, GW Kim, A Aing, B Stoecker, ... Cancer research 76 (2), 339-346, 2016 | 68 | 2016 |
| Role of muscarinic-3 receptor antibody in systemic sclerosis: correlation with disease duration and effects of IVIG S Kumar, J Singh, R Kedika, F Mendoza, SA Jimenez, ES Blomain, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 310 (11 …, 2016 | 65 | 2016 |
| Guanylyl cyclase C signaling axis and colon cancer prevention AM Pattison, DJ Merlino, ES Blomain, SA Waldman World journal of gastroenterology 22 (36), 8070, 2016 | 46 | 2016 |
| New advances in models and strategies for developing anti-obesity drugs GW Kim, JE Lin, ES Blomain, SA Waldman Expert opinion on drug discovery 8 (6), 655-671, 2013 | 46 | 2013 |
| Intestinal enteroids model guanylate cyclase C-dependent secretion induced by heat-stable enterotoxins AM Pattison, ES Blomain, DJ Merlino, F Wang, MAS Crissey, CL Kraft, ... Infection and immunity 84 (10), 3083-3091, 2016 | 38 | 2016 |
| Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2C M Witek, ES Blomain, MS Magee, B Xiang, SA Waldman, AE Snook International Journal of Radiation Oncology* Biology* Physics 88 (5), 1188-1195, 2014 | 37 | 2014 |
| Intestinal GUCY2C prevents TGF-β secretion coordinating desmoplasia and hyperproliferation in colorectal cancer AV Gibbons, JE Lin, GW Kim, GP Marszalowicz, P Li, BA Stoecker, ... Cancer research 73 (22), 6654-6666, 2013 | 32 | 2013 |
| Dynamic regulation of mitochondrial transcription as a mechanism of cellular adaptation ES Blomain, SB McMahon Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1819 (9-10 …, 2012 | 24 | 2012 |
| GUCY2C ligand replacement to prevent colorectal cancer ES Blomain, AM Pattison, SA Waldman Cancer biology & therapy 17 (7), 713-718, 2016 | 23 | 2016 |
| A step toward making VMAT TBI more prevalent: automating the treatment planning process E Simiele, L Skinner, Y Yang, ES Blomain, RT Hoppe, SM Hiniker, ... Practical radiation oncology 11 (5), 415-423, 2021 | 21 | 2021 |
| Stereotactic radiosurgery practice patterns for brain metastases in the United States: a national survey ES Blomain, H Kim, S Garg, D Bhamidipati, J Guo, I Kalchman, J McAna, ... Journal of radiation oncology 7, 241-246, 2018 | 19 | 2018 |
| The Stanford volumetric modulated arc therapy total body irradiation technique N Kovalchuk, E Simiele, L Skinner, Y Yang, N Howell, J Lewis, C Hui, ... Practical Radiation Oncology 12 (3), 245-258, 2022 | 17 | 2022 |
| NCCN Clinical Practice Guidelines in Oncology: Thyroid Carcinoma RI Haddad, L Bischoff, V Bernet, E Blomain, NL Busaidy, P Dickson, ... J. Natl. Compr. Cancer Netw 20, 925-951, 2022 | 16 | 2022 |
| Guanylyl cyclase C hormone axis at the intersection of obesity and colorectal cancer ES Blomain, DJ Merlino, AM Pattison, AE Snook, SA Waldman Molecular Pharmacology 90 (3), 199-204, 2016 | 16 | 2016 |
| Translating colorectal cancer prevention through the guanylyl cyclase C signaling axis ES Blomain, JE Lin, CL Kraft, UT Trela, JM Rock, AS Aing, AE Snook, ... Expert review of clinical pharmacology 6 (5), 557-564, 2013 | 16 | 2013 |
| Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment W Shi, ES Blomain, J Siglin, JD Palmer, T Dan, Y Wang, M Werner-Wasik, ... Journal of Neuro-Oncology 137, 171-177, 2018 | 15 | 2018 |
